Purchase Order 75F40120P00674
Award Date 9/22/20
Potential Completion Date 9/21/24
Potential Value $210K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order to Illumina, Inc. for a DRAGEN Appliance for HIVE, including the license, platform, installation, and support plan. The contract has a potential value of $255,450.00 and a completion date of August 28, 2024. Illumina, a manufacturer of goods, has previously received prime federal contracts and subcontracts from agencies such as the National Institutes of Health, Centers for...
- This is a firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for the procurement of a DRAGEN Server and associated software licenses. The DRAGEN Appliance, which utilizes field-programmable gate array (FPGA) technology, will provide hardware acceleration for genomics analysis at the FDA. The contract does not have a set-aside designation. The total ceiling value of the contract is $175,492.00, with a period of performance through...
- This is a $77,592.11 firm fixed price delivery order awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The order is for the addition of items from Requisition #1168475, with no set-aside designation. Illumina has a history of providing sequencing instruments, reagents, and related services to support genomic research and diagnostics across various federal agencies, including the National Institutes of Health (NIH),...
- This federal contract award, valued at $15,000.00, was issued by the National Human Genome Research Institute (NHGRI) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract is for a DRAGEN CS Level 1 License with a throughput of 100,000GB, with a period of performance from July 25, 2024 to July 24, 2025. The contract is a firm fixed price purchase order and does not have a set-aside designation. Illumina has previously received prime federal...
- This firm fixed-price purchase order contract was awarded by the Food and Drug Administration (FDA), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing technologies. The $576,928.00 contract is for the procurement of an Illumina NextSeq2000 Sequencing System, including associated reagents and maintenance services. The contract has a period of performance through July 20, 2026. Illumina is a key technology provider for federal scientific and diagnostic...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents, for the provision of a next generation sequencer. The contract has a potential value of $100,980.00 and a completion date of August 28, 2020. Illumina has provided similar sequencing systems and consumables to support genomic research and diagnostics across various federal agencies such as the National...
- This is a delivery order awarded by the Food and Drug Administration (FDA), a civilian agency, to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $113,869.74, is for amending prices and adding a list of items, with a completion date of August 10, 2016. The contract is a firm fixed-price delivery order and does not have a set-aside designation. Illumina has previously received prime federal contract awards from...
- This federal contract award by the Department of Health and Human Services Food and Drug Administration adds $110,510.96 in funding to an original requisition with Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The contract is a firm fixed price Delivery Order with no set-aside designation. Illumina has previously provided sequencing systems, consumables, and support services to various government agencies for research and diagnostics. This award likely supports...
- This is a firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract has a ceiling value of $924,805.20 and a period of performance ending on March 23, 2019. The award is for the provision of high-throughput sequencing equipment and services, with no set-aside designation. Illumina has a history of supporting genomic sequencing and analysis requirements across various...
- This is a firm fixed price delivery order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract has a ceiling value of $237,188.40 and no set-aside designation. Illumina will provide a range of sequencing systems, including NextSeq, NovaSeq, MiSeq, and iSeq, along with associated reagents, consumables, sample prep kits, sequencing chips, support plans, maintenance services, and...